Arkolith/Insider Trading/SCPH/Form 4

Tucker John H

President and CEO, DirectorscPharmaceuticals Inc. (SCPH) · full profile →Form 4 · filed Oct 7, 2025
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
6
2 non-derivative · 4 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 7, 2025Tender(U)122K——319K
Oct 7, 2025Disposed to issuer(D)319K——0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Oct 7, 2025Disposed to issuer(D)249K—$00
Oct 7, 2025Disposed to issuer(D)497K—$00
Oct 7, 2025Disposed to issuer(D)85K—$00
Oct 7, 2025Disposed to issuer(D)300K—$00

Transaction Codes

U
See SEC Form 4 code table
D
Disposition to the issuer

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-233532) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML